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Ab s t r Ac t 
Background: Several studies have shown the neuroprotective role afforded by hypoxic and ischemic preconditioning in cerebrovascular 
disorders. There are several clinical conditions which simulate the hypoxic and ischemic conditioning in humans. The aim of this retrospective 
study is to identify whether the presence of any clinical scenarios mimicking the hypoxic and ischemic conditions prior to the current acute 
ischemic stroke (AIS) has a neuroprotective role in these patients.
Materials and methods: Data were collected for patients >18 years of age who underwent endovascular treatment for AIS from January 
2009 to June 2015. A good outcome was defined as modified Rankin score (mRS) of 0 to 3 at discharge and a poor outcome as mRS of 4–6. 
A logistic regression analysis was performed to identify independent predictors of outcomes at discharge in both groups. A p value of <0.05 
was considered statistically significant for all analyses.
Results: A total of 102 patients, aged 67 ± 16 years with median preprocedural National Institute of Health Stroke Scale (NIHSS) score 17.5 (1–36), 
were included. Twenty-one (21%) patients had a good outcome (mRS: 0–3) and 81 (79%) had a poor outcome (mRS: 4–6). A logistic regression 
analysis identified higher NIHSS score [odds ratio (OR): 1.251, confidence interval (CI): 1.11–1.40, p = 0.0002] and history of transient ischemic 
attack (TIA; OR: 7.881, CI: 1.05–21.01, p < 0.04) as predictors of a poor outcome at discharge.
Conclusion: Our data suggest that the occurrence of TIA preceding an AIS may be associated with the poor outcomes in patients with AIS, 
although this finding needs confirmation in larger studies.
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In t r o d u c t I o n 
Conditioning is a strategy where a sublethal noxious stimulus 
presented to any tissue in the body invokes endogenous protective 
mechanisms so that the organ develops tolerance toward 
subsequent similar or stronger insult. A variety of conditioning 
agents have been shown to provide protection in a variety of 
organ systems through conditioning-based mechanisms.1–3 
Although initially applied for cardiac protection, this application 
has been shown to elicit therapeutic benefits for various organ 
systems such as brain, liver, kidney, lung, pancreas, skin, skeletal 
and smooth muscle, and the peripheral vasculature.4 Conditioning 
against brain injury can be induced by various conditions and 
agents such as ischemia,4–7 hypoxia,6–9 anesthetics,3 thrombin,2 
lipopolysaccharides,1 and many drugs some of which have already 
been approved by Food and Drug Administration.
Hypoxia and ischemia are the two most commonly studied 
conditioned stimuli in various central nervous system pathologies, 
and there are several animal and clinical studies which have shown 
the neuroprotective role of hypoxic and ischemic preconditioning 
in acute ischemic stroke (AIS).4–9 Certain clinical comorbidities, such 
as chronic obstructive pulmonary disease (COPD), obstructive sleep 
apnea (OSA),10,11 TIA,12–15 and peripheral vascular disease (PVD)16 
may simulate the hypoxic and ischemic preconditioning state. 
The aim of our study is to assess the neurovascular protective role 
of various clinical scenarios which imitate hypoxic and ischemic 
conditions in patients who presented with AIS.
MAt e r I A l s A n d Me t h o d s 
After institutional review board approval, data were collected 
from all patients >18 years of age who underwent endovascular 
treatment of AIS at our comprehensive stroke center from January 
2009 to June 2015. A total of 106 patients were treated during the 
study period. Out of 106, 102 patients had conscious sedation and 
4 patients had general anesthesia. Patients treated under general 
anesthesia were excluded. Data on comorbid diseases, medication 
history, laboratory parameters, and social history were collected 
from electronic medical records. The NIHSS score and the mRS at 
discharge and at 3 months were obtained from the Department of 
Neurology database. The NIHSS score was evaluated by vascular 
neurology residents and fellows, and the mRS score was evaluated 
by stroke nurses certified in the use of the mRS instrument. The 
primary outcome measure is the mRS at discharge. A good outcome 
is defined as mRS of 0–3 and a poor outcome as mRS of 4–6.
Statistical Analysis
The clinical conditions of patients with a good outcome were 
compared with those of patients with a poor outcome using 
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the univariate analysis with Chi-square test, Fisher’s exact test, 
independent t test, and Mann–Whitney test, as appropriate. 
Variables which are not normally distributed are represented 
as median (minimum, maximum). A logistic regression analysis 
was performed with a neurologic outcome at discharge as the 
dependent variable, using the ENTER method, to evaluate factors 
of interest (age, history of TIA, and pre-procedural NIHSS score) 
as independent predictors of a poor outcome at discharge. The 
overall fit of the regression model was assessed using the c-statistic, 
measuring the area under the receiver-operating characteristic 
(ROC) curve (AUC) and with Hosmer and Lemeshow test as a 
measure of goodness of fit. Statistical analyses were performed 
using MedCalc for Windows, version 18.11 (MedCalc Software, 
Ostend, Belgium). A p value of <0.05 was considered statistically 
significant for all analyses.
re s u lts 
A total of 102 patients (81 men and 21 women), aged 67 ± 16 years, 
were included. The anterior cerebral circulation was affected in 88 
patients (86%), and the median preprocedural NIHSS score was 17.5 
(1–36). Overall, 21 (21%) patients had a good outcome (mRS: 0–3), 
and 81 (79%) had a poor outcome (mRS: 4–6).
Table 1 shows the various clinical conditions for patients with 
a good outcome vs patients with a poor outcome at discharge. 
In this series, patients with the good outcomes had significantly 
lower NIHSS score (p ≤ 0.0001) and lower incidence of TIA prior to 
the current stroke (p = 0.007). There was no significant difference 
between the two groups with respect to age, gender, hypertension, 
atrial fibrillation, diabetes, renal insufficiency, anemia, coronary 
artery disease, congestive heart failure, valvular problems, 
OSA, COPD, thyroid problems, pulmonary embolism, deep vein 
thrombosis, cancer history, smoking, alcohol, drug abuse, and use 
of medications.
Table 2 shows the subgroup analysis between patients with 
and without TIA. Significant differences between patients with 
and without TIA were found for the following variables: NIHSS 
score at the presentation (p = 0.037), history of stroke (p ≤ 
0.0001), hyperlipidemia (p = 0.002), hypertension (p < 0.0001), 
cardiomyopathy (p = 0.005), and hypothyroidism (p = 0.03). 
No significant differences were noted between the two groups 
for the variables age, gender, atrial fibrillation, diabetes, renal 
insufficiency, anemia, coronary artery disease, congestive heart 
failure, valvular problems, OSA, COPD, pulmonary embolism, deep 
vein thrombosis, cancer history, smoking, alcohol, drug abuse, and 
use of medications.
Table 3 shows the results of the logistic regression analysis 
done to identify independent factors predicting a poor outcome 
at discharge. The final multivariable logistic regression model had 
very good discrimination (c-statistic of 0.85) and good calibration 
(Hosmer–Lemeshow test, Chi-square = 7.47, p = 0.48) with overall 
Table 1: Comparison of clinical characteristics in patients with good vs poor outcomes based on modified 
Rankin score
Variable
Good outcome  
(mRS: 0–3), n = 21
Poor outcome  
(mRS: 4–6), n = 81 p value
Age 70 (38, 86) 70 (19, 90) 0.719
Sex (F/M) 13/8 45/36 0.601
Hematocrit 36.6 (25, 46) 37 (19, 49) 0.331
Preprocedural NIHSS score 13 (1, 23) 20 (8, 36) < 0.0001
History of stroke 3 16 0.413
History of TIA 3 38 0.007
Hypertension 13 65 0.077
A-fib 6 28 0.603
Diabetes 6 25 0.839
Renal insufficiency 3 15 0.650
Anemia 13 47 0.747
COPD 2 12 0.413
Drug abuse 2 8 0.662
Alcohol use 5 23 0.675
Tobacco use 5 34 0.127
Coronary disease 6 24 0.924
Myocardial infarction 1 6 0.669
Valve disease 2 9 0.834
CHF 3 17 0.491
Cardiomyopathy 2 13 0.452
Hypothyroidism 1 13 0.163
PVD 0 3 0.497
DVT 0 3 0.497
PE 0 2 0.629
OSA 1 7 0.480
Data are presented as median (minimum, maximum) or frequency as appropriate; p < 0.05 is statistically significant; 
CHF, congestive heart failure; DVT, deep venous thrombosis; PE, pulmonary embolism; A-fib, atrial fibrillation
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AUC 0.85 (Fig. 1). The NIHSS score (OR: 1.25, CI: 1.11–1.40, p = 0.0002) 
and previous TIA (OR: 4.70, CI: 1.05–21.01, p = 0.04) were shown to 
be significant predictors of a poor outcome at discharge.
dI s c u s s I o n 
The main finding in our study is that the patients with history of 
previous TIA and subsequent AIS have poor prognosis compared 
with patients without history of TIA. This finding contradicts the 
findings of several clinical and animal studies where TIA was shown 
to confer neurovascular protection, presumably due to ischemic 
preconditioning, although controversial evidence exists related 
to the history of previous TIA and the outcomes of consequent 
AIS.12–25 Ischemic stroke is one of the common reasons for mortality 
and morbidity throughout the world, and it is well known that the 
occurrence of TIA increases the risk of consecutive ischemic stroke.26 
Knowledge regarding the effects of TIA on the subsequent attack 
of the ischemic stroke is critical as therapies can be effectively used 
to prevent the recurrent stroke.
Table 2: Comparison of patients with vs without history of transient ischemic attack
Variable
Patients without  
TIA (n = 61)
Patients with  
TIA (n = 41) p value
Age 66.7 ± 16.5 66.7 ± 15.4 0.997
Men/women 26/35 18/23 1.000
Hematocrit 36.2 ± 6.9 36.4 ± 5.8 0.882
Preprocedural NIHSS score 16 (7, 35) 20 (1, 36) 0.037
History of stroke 3 16 < 0.0001
HLD 23 28 0.002
Hypertension 39 39 < 0.0001
A-fib 19 15 0.568
Diabetes 15 16 0.120
Renal insufficiency 9 9 0.350
Anemia 35 25 0.717
COPD 9 5 0.713
Drug abuse 8 2 0.308
Alcohol use 18 10 0.570
OSA 3 5 0.180
Tobacco use 24 15 0.779
Coronary disease 13 17 0.029
MI 3 4 0.343
Valve disease 6 5 0.706
CHF 10 10 0.319
Cardiomyopathy 4 11 0.005
Hypothyroidism 12 2 0.033
PVD 2 1 0.806
DVT 3 0 0.149
PE 1 1 1.000
Data are summarized as mean ± standard deviation, median (minimum, maximum) or number of cases. Variables were 
compared between groups using Student’s t test, Mann–Whitney, Chi-square, or Fisher’s exact test as appropriate; 
CHF, congestive heart failure; DVT, deep venous thrombosis; PE, pulmonary embolism; MI, myocardial infarction; 
HLD, hyperlipidemia; A-fib, atrial fibrillation
Table 3: Logistic regression anal ysis to evaluate predictors of a poor 
outcome at discharge
Variable p value OR 95% CI
Age 0.48 0.98 0.95–1.02
History of TIA 0.04 4.70 1.05–21.01
Preprocedural NIHSS score 0.0002 1.25 1.11–1.40
Values are represented as OR and 95% CI; p < 0.05 is statistically significant
Fig. 1: Receiver operating characteristic curve for the predictor variables 
and the entire model. Area under the curve for the overall model is 0.851
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Ischemic conditioning is a commonly applied powerful strategy 
which is shown to have strong protective effects in various organs, 
including the brain.27 Ischemic conditioning not only provides 
neuronal protection but also protection against other components 
of the neurovascular network such as glia and vascular endothelial 
cells.27 The neuroprotection through ischemic conditioning is 
proposed to occur through multiple mechanisms such as (1) 
depression of cerebral metabolism and activity, (2) activation of 
signaling pathways and mechanisms at the cellular level, (3) changes 
in mitochondrial functions, and (4) alterations of excitatory and 
inhibitory neurotransmitters and other processes.27
Clinical conditions such as TIA, COPD, OSA, and PVD may 
result in a naturally occurring ischemic preconditioning process. 
Obstructive sleep apnea is a disease condition where patients 
are exposed to repeated short episodes of hypoxemia through 
multiple apneic episodes during sleep. The intermittent hypoxia 
caused by these apneic episodes simulates the ischemic/hypoxic 
conditioning and stimulates the adaptive responses responsible for 
the neuroprotection.10,11 Similarly, patients with PVD and chronic 
limb hypoperfusion can provide neuroprotection against ischemic 
stroke through a concept called remote ischemic preconditioning.16 
It is difficult to exclude the effects of these clinical conditions on the 
severity of ischemic stroke in our study because of the relatively 
small sample size.
Transient ischemic attack is a process which naturally correlates 
well with ischemic preconditioning. Few articles suggest that 
history of TIA is associated with the poor outcomes in ischemic 
stroke patients presented that (1) silent infarcts or TIAs did not 
influence the long-term outcomes or mortality of ischemic stroke 
patients,28,29 (2) the concept of ischemic preconditioning may be 
lost in elderly patients due to the age-related loss of endogenous 
mechanisms protecting against cerebral ischemia,19,22 and (3) 
history of TIA is associated with a poor functional outcome at 3 
months and the atherothrombotic stroke and vascular risk factors 
were higher in the TIA group compared with patients without TIA.17
Articles supporting the role of TIA in ischemic preconditioning 
have shown that (1) previous ipsilateral TIAs with subsequent 
anterior circulation stroke present with less stroke severity and have 
better functional outcomes,15 (2) the duration of TIA and the timing 
of the subsequent stroke may have an impact on prognosis15,18,22 
although this was not supported by Weber et al.,13 (3) previous TIA 
in the same vascular territory of the current stroke may have better 
prognosis,23 (4) have a protective role in lacunar19 and nonlacunar 
ischemic strokes,12 (5) lower stroke severity at presentation,13 and 
(6) preceding TIA was associated with reduced hospitality case 
fatality rate.25 Although controversial evidence exists in reference 
to the protective effects of TIA on the ischemic stroke, it has been 
shown that TIA is protective if it is recent, occurred multiple times 
with a shorter duration.
The results from our study do not completely rule out the 
protective effects of ischemic conditioning in the ischemic stroke 
patients, because the outcome after AIS depends on several 
factors, including (1) acuity vs chronicity of the TIA; (2) latency of 
TIA to the successive stroke, number of TIAs before the stroke, side, 
vascular territory, and severity of the previous TIA; (3) etiology of the 
stroke; and (4) treatments provided for the TIA and the subsequent 
infarction.
Limitations of our study include (1) the fact that this is a 
single-center study; (2) retrospective data collection; (3) relatively 
small sample size and possible selection bias, so that the study is 
likely underpowered to evaluate clinically important associations 
between all hypoxic/ischemic conditions with the neurologic 
outcomes; (4) could not retrieve the information regarding anterior 
vs posterior TIA and their treatment with antiplatelet medications; 
and (5) classification of the outcomes with mRS (0–3)30,31 was based 
on the functional independence although many agree that mRS 
(0–2) better reflects the reality of the good outcome. The poor 
outcome trend in our patient group may be related to our previous 
selection criteria for the procedure. Nevertheless, prophylactic 
measures should be taken to mitigate or prevent risk factors after 
the occurrence of TIA, in an attempt to reduce the risk of subsequent 
ischemic stroke.
co n c lu s I o n 
Our data suggest that history of previous TIA and higher NIHSS score 
at presentation are predictors of the poor outcomes at discharge in 
patients with AIS. Despite the significant limitations of this study, 
measures should be taken to minimize the risk factors after TIA in 
an attempt to reduce the risk of subsequent stroke.
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